|
|||||
|
|
Phase I study of capecitabine,oxaliplatin, bevacizumab,and everolimus in advanced solid tumors |
|
| Authors: | Fatima Rangwala Johanna C. Bendell Mark F. Kozloff Christy C. Arrowood Andrew Dellinger Jennifer Meadows Sandra Tourt-Uhlig Jennifer Murphy Kellen L. Meadows Aijing Starr Samuel Broderick John C. Brady Stephanie M. Cushman Michael A. Morse Hope E. Uronis S. David Hsu S. Yousuf Zafar James Wallace Alexander N. Starodub John H. Strickler Herbert Pang Andrew B. Nixon Herbert I. Hurwitz |
| Affiliation: | 1. Duke University Medical Center, Seeley G. Mudd Bldg 10 Bryan Searle Drive, Box 3052, Durham, NC, 27710, USA 2. Sarah Cannon Research Institute, Nashville, TN, USA 3. Ingalls Memorial Hospital/Cancer Research Center, Harvey, IL, USA 4. Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, NC, USA 6. Duke Clinical Research Institute, Durham, NC, 27705, USA 5. Goshen Center for Cancer Care, Goshen, IN, 46526, USA |
| Abstract: | |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ | |